TY - JOUR
KW - Adolescent
KW - Adult
KW - Analgesics, Opioid/adverse effects
KW - Buprenorphine/adverse effects
KW - Female
KW - Humans
KW - Infant Behavior/drug effects
KW - Infant, Newborn
KW - Linear Models
KW - Male
KW - Methadone/adverse effects
KW - Morphine/administration & dosage/therapeutic use
KW - Neonatal Abstinence Syndrome/drug therapy/physiopathology
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - Pregnancy
KW - Pregnancy Complications/drug therapy
KW - Prenatal Exposure Delayed Effects
KW - Severity of Illness Index
KW - Young Adult
AU - M. G. Coyle
AU - A. L. Salisbury
AU - B. M. Lester
AU - H. E. Jones
AU - H. Lin
AU - K. Graf-Rohrmeister
AU - G. Fischer
A1 - 
BT - Addiction (Abingdon, England)
C5 - Opioids & Substance Use; Healthcare Disparities
CY - England
DO - 10.1111/j.1360-0443.2012.04040.x
JF - Addiction (Abingdon, England)
PB - Society for the Study of Addiction
PP - England
PY - 2012
SN - 1360-0443; 0965-2140
SP - 63
EP - 73
EP - 
T1 - Neonatal neurobehavior effects following buprenorphine versus methadone exposure
T2 - Addiction (Abingdon, England)
TI - Neonatal neurobehavior effects following buprenorphine versus methadone exposure
U1 - Opioids & Substance Use; Healthcare Disparities
U2 - 23106928
U3 - 10.1111/j.1360-0443.2012.04040.x
VL - 107 Suppl 1
VO - 1360-0443; 0965-2140
Y1 - 2012
ER -